Young Therapeutics, Llc

Young Therapeutics, LLC is a Philadelphia Biotech company focused on preventing reperfusion injury. When an artery is clogged (stroke or heart attack), the tissue down stream is cut off from oxygen carrying blood resulting in ischemic damage. In both the setting of stroke and heart attack, it is essential the blood flow be restored as quickly as possible however when oxygen is re-introduced to the ischemic tissue, damaging oxygen free radicals are generated which become another source of tissue injury. Young Therapeutics has patented technology that minimizes the damage caused by reperfusion. Animal studies in cardiac ischemia Young Therapeutic's lead compound - YT-001 showed a 70% reduction in damage compared to control. Preventing such damage will result in increased survivability, decreased morbidity and may prevent the development of ischemic heart failure. FCOI Policy: & st=627v0lx7 & dl=0